simeprevir

This page shows the latest simeprevir news and features for those working in and with pharma, biotech and healthcare.

Remicade safe from biosimilar competition this year, says J&J

On the downside, hepatitis C therapy Olysio/Sovriad (simeprevir) continued its decline in the face of strong competition in the marketplace from Gilead and AbbVie, falling 86% to just $32m in

Latest news

2015's 'premium' prices dissuaded J&J from acquisitions, says Gorsky

to $8.1bn despite heavy competition to hepatitis C therapies Olysio (simeprevir) and Incivo (telaprevir) from Gilead and AbbVie.
J&J's share buyback 'doesn't prevent acquisitions'

disease and arthritis drug Remicade (infliximab) and Olysio (simeprevir) for hepatitis C virus offset by growth in newer products.
J&J starts to feel biosimilar competition bite

its toll on J&J's Olysio (simeprevir) and Incivek (telaprevir) products.
J&J signs $1bn deal with Achillion for hepatitis C therapies

J&J already has one new-generation oral HCV therapy on the market, its NS3/4A protease inhibitor Olysio (simeprevir), but could do with additional drugs in its portfolio in order
Harvoni sales rocket in first quarter

simeprevir), while Merck &Co also has a new treatment in the works.

More from news
Approximately 9 fully matching, plus 34 partially matching documents found.

Latest Intelligence

Taking a strategic approach

Meanwhile, for Olysio (simeprevir) - one of several new oral drugs that mark a major step forward in hepatitis C treatment - it was an innovative 'pay-if-you-clear' scheme that persuaded

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Medivir names new CEO

simeprevir). “ Medivir is an attractive company in an exciting phase of its development following the successful market introduction of simeprevir,” he said. “

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Warehousing of HCV patients reaches new high

Gilead’ s interferon-free product sofosbuvir and Johnson &Johnson’ s simeprevir appear to lead the field – receiving the highest levels of spontaneous and prompted awareness. ... However, Abbvie’ s products ABT 267, ABT 333 and ABT 450 remain
Warehousing of HCV patients reaches new high

Gilead’ s interferon-free product sofosbuvir and Johnson &Johnson’ s simeprevir appear to lead the field – receiving the highest levels of spontaneous and prompted awareness. ... However, Abbvie’ s products ABT 267, ABT 333 and ABT 450 remain

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Associate Director, Market Access & HEOR – North-West: Negotiable

Associate Editorial Director – Med Comms – London: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Associate Medical Director: Excellent PTO, bonus and 401k package

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Medical Writers Required – Cheshire: DOE

Client Services Director – Medical Education Agency – North West...: Salary TBC

Associate Director: £75, 000-90, 000

Events Manager – Med Comms – Surrey: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Account Director development role to Business Director, H...: Excellent package

Account Manager- Healthcare Advertising: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Medical Director: Highly Competitive

Account Manager / Account Director: Competative

Senior Medical Writer: Competitive Salary

Subscribe to our email news alerts

PMHub

Add my company

COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...